Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 150 clinical trials
Featured trial
A study for adults with severe alopecia areata comparing amlitelimab (subcutaneous injections) to placebo

Test ETL

  • 0 views
  • 03 Dec, 2024
  • 3 locations
Featured trial
A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination

>

  • has spread to other parts of the body (metastatic).
    • ul>
    This includes (but limited to) the following cancer types:
    <ul>
  • Non-Small Cell Lung Cancer (NSCLC): It's a type of

    • 0 views
    • 03 Dec, 2024
    • 4 locations
    Featured trial
    A Study to Evaluate INCA033989 Administered in Participants With Myeloproliferative Neoplasms

    ) of INCA033989 administered in participants with myeloproliferative neoplasms.

    • 0 views
    • 14 Jan, 2025
    • 3 locations
    Featured trial
    Remote Assessment and Intervention for Behavior Problems in Kids With TSC

    The RAINBOW study is a fully remote study focused on understanding and treating behavior problems in young children with tuberous sclerosis complex (TSC). The first goal is to enroll a group of 100 children with TSC between the ages of 3 and 6 years old, with and without problem behaviors, …

    • 0 views
    • 22 Nov, 2024
    • 1 location
    Featured trial
    Characterization of Tissue-Specific Immune Responses to Bronchoscopic Instillation of Mycobacterial Antigens Into the Human Lung

    Background Tuberculosis (TB) is a lung disease. It is caused by inhaling a type of airborne bacterium. Tuberculin Purified Protein Derivative (PPD) is used to test for TB exposure. It is usually injected under a person s skin. In this study, it will be applied in the lung. Objective To …

    Accepts healthy volunteers
    • 0 views
    • 20 May, 2025
    • 2 locations
    Featured trial
    Single Ascending Dose Study of SAR439459 in Adults With Osteogenesis Imperfecta (OI)

    SAR439459 is a human anti-Transforming growth factor β (TGFβ) monoclonal antibody. This phase 1 clinical study investigates the safety, tolerability, and activity of a single dose of SAR439459 in adult participants with OI. Participants will receive a single IV dose of SAR439459 with safety, pharmacokinetic (PK), and pharmacodynamic (PD) assessments …

    • 0 views
    • 21 Mar, 2024
    • 4 locations
    Featured trial
    Stem Cell Ophthalmology Treatment Study II

    This study will evaluate the use of autologous bone marrow derived stem cells (BMSC) for the treatment of retinal and optic nerve damage or disease.

    • 0 views
    • 03 Dec, 2024
    • 3 locations
    Featured trial
    A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it)

    This study is to evaluate the Pharmacodynamic (PD), safety, tolerability, Pharmacokinetic (PK), and plasma biomarker response of KAN-101 in participants with Celiac Disease (CeD).

    • 0 views
    • 08 Nov, 2024
    • 1 location
    Featured trial
    Multi-language Solution - Single Study  

    Interim Workaround for multi-language secondary pre-screeners.

    • 0 views
    • 08 May, 2025
    • 3 locations
    Featured trial
    Digital Intervention for Psychedelic Preparation (DIPP): Comparing Meditation and Music-Based Programs

    (recruitment rates and participant retention) and intervention adherence (completion rates of DIPP program activities). Secondary outcomes include participant ratings of the platform's feasibility, acceptability

    Accepts healthy volunteers
    • 0 views
    • 10 Feb, 2025
    • 1 location